29P Long-term performance of residual cancer burden (RCB): Clinical pathological stage (CPS) and CPS+ER+Grade (CPS-EG) models in ER+HER2- breast cancer (BC) patients (pts) after neoadjuvant chemotherapy (NAC) - Role of Ki67 drop and extended endocrine therapy (EET)
Gomez, L. Sanz, Adelantado, E. Zamora, Joval, L., Monescillo, E., Ortiz, C., Trabulo, C.F.P., Garcia, B. Rojas, Pascual, J., Puerto, D.A. Gomez, Salazar, S.A. Bueno, Rivero, J., Gómez, I. Miranda, Ariza, L. Rodriguez, Pardo, P. Gomez, Espinosa-Bravo, M., Manich, C. Saura, Javierre, G. Villacampa, Cámara, V. Peg, Dienstmann, R., Ezquerra, M. Bellet
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
Prognostic estimates of Ki-67 percentage drop after neoadjuvant chemotherapy (NAC) in luminal B (lumB) and triple negative breast cancer (TNBC)
Pascual, J., Rojas-Garcia, B., Peg, V., Diaz-Botero, S., Zamora, E., Muñoz Couselo, E., Oliveira, M., Gomez Pardo, P., Perez Garcia, J., Ruiz-Pace, F., Viaplana, C., Escrivá, S., Garrigos, L., Arumi, M., Espinosa-Bravo, M., Cortés, J., Rubio, I., Saura, C., Dienstmann, R., Bellet Ezquerra, M.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article